173 related articles for article (PubMed ID: 8011274)
1. Synthesis and inhibitory effects of 1,4,5-trialkyl-2-thioimidazole derivatives on platelet aggregation.
Fatimi J; Lagorce JF; Chabernaud ML; Buxeraud J; Raby C
Boll Chim Farm; 1994 Mar; 133(3):151-5. PubMed ID: 8011274
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of copper-aspirin complex on platelet aggregation.
Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro.
Shan CW; Lin JH; Jin YH
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):164-6. PubMed ID: 10374644
[TBL] [Abstract][Full Text] [Related]
4. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
5. [Influences of 3,4,5-trihydroxystibene-3-beta-mono-D-glucoside on rabbits' platelet aggregation and thromboxane B2 production in vitro].
Shan CW; Yang SQ; He HD; Shao SL; Zhang PW
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):527-30. PubMed ID: 2130618
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antithyroid activity of 1,4,5-trialkyl 2-thioimidazole derivatives.
Fatimi J; Lagorce JF; Chabernaud ML; Comby F; Buxeraud J; Raby C
Farmaco; 1994 Apr; 49(4):253-7. PubMed ID: 7519428
[TBL] [Abstract][Full Text] [Related]
7. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
Qu YZ; Wang YE; Li XX
Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
[TBL] [Abstract][Full Text] [Related]
8. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
9. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
11. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
13. [Effects of 6-(alpha alpha-diphenylacetylpiperazinyl) phenyl-5-methyl-4,5-dihydro-3 (2H)-pyridazinone on rabbit platelet aggregation and TXB2, cAMP production].
Zeng GQ; Wang XS; Sun DX; Lin AY; Ji Y; Chu JX; Rui YC
Yao Xue Xue Bao; 1993; 28(4):256-9. PubMed ID: 8213167
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro study of platelet antiaggregant activity of some 4-quinazolinone derivatives.
Gravier D; Dupin JP; Casadebaig F; Hou G; Boisseau M; Bernard H
Pharmazie; 1992 Feb; 47(2):91-4. PubMed ID: 1635928
[TBL] [Abstract][Full Text] [Related]
18. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
19. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood.
González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP
Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation.
Del Zar MM; Martinuzzo M; Falcón C; Cardinali DP; Carreras LO; Vacas MI
J Clin Endocrinol Metab; 1990 Jan; 70(1):246-51. PubMed ID: 2294133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
